U.S. markets close in 1 hour 50 minutes
  • S&P 500

    4,151.18
    -0.14 (-0.00%)
     
  • Dow 30

    33,978.79
    -8.39 (-0.02%)
     
  • Nasdaq

    12,134.88
    -22.84 (-0.19%)
     
  • Russell 2000

    1,791.07
    -11.77 (-0.65%)
     
  • Crude Oil

    81.23
    +0.40 (+0.49%)
     
  • Gold

    2,016.80
    +9.80 (+0.49%)
     
  • Silver

    25.25
    +0.16 (+0.65%)
     
  • EUR/USD

    1.0973
    +0.0043 (+0.40%)
     
  • 10-Yr Bond

    3.5810
    -0.0100 (-0.28%)
     
  • GBP/USD

    1.2428
    +0.0050 (+0.40%)
     
  • USD/JPY

    134.0610
    -0.3630 (-0.27%)
     
  • Bitcoin USD

    30,013.93
    +514.05 (+1.74%)
     
  • CMC Crypto 200

    670.62
    +7.88 (+1.19%)
     
  • FTSE 100

    7,909.44
    +29.93 (+0.38%)
     
  • Nikkei 225

    28,658.83
    +144.05 (+0.51%)
     

DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DENVER, April 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

DaVita Logo (PRNewsfoto/DaVita)
DaVita Logo (PRNewsfoto/DaVita)

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

Monday, May 8, 2023
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link 
Dial in number: 877-918-6630
International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2022, DaVita served 200,000 patients at 2,724 outpatient dialysis centers in the United States. The company also operated 350 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information 
Investors:
IR@davita.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-1st-quarter-2023-investor-conference-call-301800709.html

SOURCE DaVita